Sclavo Diagnostics International S.p.A.

Sclavo Diagnostics International S.p.A. is a leader in research, development, production, and marketing of in vitro clinical diagnostic reagents for Clinical Chemistry. The company has a rich history, founded in 1904 by Achille Sclavo who developed the serum against anthrax and later established the Sclavo Institute for Serum and Vaccine Production in Tuscany. Over the years, the company has expanded its product portfolio to include diagnostic reagents for various medical applications. Based in Italy, Sclavo Diagnostics International prides itself on its expertise, long-standing experience, and quality control processes that ensure the best value for its customers. The company's offerings cover a range of areas including clinical chemistry, specific and urinary proteins, coagulation, serology, research, and development. With a focus on quality, the company also serves as an ideal partner for the production of bulk reagents and OEM kits tailored to specific product requirements and packaging needs. Overall, Sclavo Diagnostics International S.p.A. stands as a testament to longevity and innovation in the Health Care and Pharmaceutical industries. While specific details regarding recent investments and investors are not available at present, the company's established presence and commitment to quality and innovation make it a compelling prospect for potential investors and strategic partners alike.